Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing presents detailed voting tallies for three proposals: election of four Class II directors (Proposal 1), advisory say-on-pay vote on named executive officer compensation (Proposal 2), and ratification of RSM US LLP as independent auditors (Proposal 3). All three proposals passed, with specific vote counts provided for each nominee and proposal. This is a material disclosure as shareholder voting results directly inform investors about governance and executive compensation approval.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
MetaVia held its Annual Meeting of Stockholders on June 8, 2026, with shareholders voting on five proposals: election of Class I directors, ratification of auditors, approval of a reverse stock split, amendment to the 2022 Equity Incentive Plan increasing available shares by 200,000, and adjournment authority. All proposals received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the final results of Capricor's Annual Meeting of stockholders held on June 4, 2026. The filing presents detailed voting tallies for all five proposals, including election of eight directors, ratification of auditors, advisory votes on executive compensation and frequency, and a failed amendment to the Certificate of Incorporation. Shareholder vote results are material to investors as they determine board composition and governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Jefferson Capital's Annual Meeting of Stockholders held on June 5, 2026. The filing presents voting tallies for two proposals: election of three Class I directors (David Burton, Thomas Harding, and Thomas Lydon, Jr.) and ratification of Deloitte & Touche LLP as independent auditor. All proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Innodata's Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes for four proposals: election of five directors, ratification of BDO India Services as independent auditors, advisory approval of named executive officer compensation, and approval of the Amended and Restated Equity Compensation Plan. All proposals passed with substantial majorities, making this a material governance event that investors rely upon to assess board composition and executive accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Alarm.com's June 3, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies on three proposals: election of eight directors, ratification of PricewaterhouseCoopers LLP as auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely on to assess board composition and management accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Ionis Pharmaceuticals held its Annual Meeting of Stockholders on June 4, 2026, with voting results disclosed for five proposals: director elections (Berthelsen and Herman), advisory compensation vote, equity plan amendment (9.5M shares), employee stock purchase plan amendment, and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 disclosure reports the results of AtaiBeckley Inc.'s annual meeting of stockholders held on June 4, 2026, including voting outcomes for the election of three Class I directors (Sabrina Martucci Johnson, Amir Kalali, M.D., and Andrea Heslin Smiley) and ratification of Deloitte & Touche LLP as independent auditor. The filing explicitly states all three nominees were elected and Proposal 2 was approved, making this a standard shareholder vote results disclosure that is material to investors' understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-06-08
Item 8.01
The filing discloses results of a stockholder vote at the 2026 Annual Meeting of Stockholders held on June 8, 2026, where shareholders approved an amendment to the terms of the STRC preferred stock to change dividend payment frequency from monthly to semi-monthly. This is a shareholder vote result on a material corporate action affecting preferred stock terms.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from Ambiq Micro's 2026 Annual Meeting held on June 8, 2026, reporting final voting tallies for two proposals: election of Class I directors (Timothy Chen and Ker Zhang, Ph.D.) and ratification of KPMG LLP as independent auditor. The filing directly matches Item 5.07 requirements and is material to investors as it documents stockholder approval of board composition and audit firm selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from the June 5, 2026 Annual Meeting of Stockholders, reporting the outcomes of three proposals: election of three Class II directors (Jane Chung, Connie Matsui, and James Panek), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The tabulated voting results with shares for, against, withheld, and abstaining are the hallmark of Item 5.07 disclosure and constitute material information about corporate governance actions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from Red Rock Resorts' Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes for three proposals: election of five directors (Frank J. Fertitta III, Lorenzo J. Fertitta, Robert A. Cashell Jr., Robert E. Lewis, and James E. Nave), a say-on-pay advisory vote, and ratification of Ernst & Young LLP as independent auditor. All proposals passed with majority support, making this a material disclosure of shareholder meeting outcomes required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This 8-K Item 5.07 discloses the final voting results from CG Oncology's June 4, 2026 Annual Meeting of Stockholders, including four proposals: election of two Class II directors (Christina Rossi and Victor Tong, Jr.), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The disclosure presents detailed vote tallies for each matter, which is the core content of Item 5.07 shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-08
Item 5.07
The Company held its 2026 Annual Meeting of Stockholders on June 3, 2026, with voting results reported for four proposals: election of seven directors (all elected with majority support), ratification of Deloitte Touche LLP as independent auditor, advisory vote on executive compensation frequency (1-year preference), and advisory approval of executive compensation policies.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Vince Holding Corp. held its 2026 Annual Meeting on June 4, 2026, with shareholders voting on four proposals: election of Class III director Michael Mardy, ratification of PricewaterhouseCoopers as auditor, advisory approval of named executive officer compensation, and approval of an amendment to the stock plan increasing authorized shares by 1,000,000. The filing reports the tabulated vote counts for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from Beam Therapeutics' June 3, 2026 annual meeting, covering three proposals: election of Class III directors (John Evans, John Maraganore, and Christi Shaw), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing directly matches Item 5.07 requirements and presents tabulated vote counts for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 filing discloses the results of Dyne Therapeutics' 2026 Annual Meeting of Stockholders held on June 5, 2026, including votes on director elections (David Lubner, Brian Posner, Jason Rhodes), advisory compensation approval, authorization of additional common shares (200M to 400M), officer exculpation amendment, and auditor ratification. The filing presents tabulated voting results for each matter, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
Item 5.07
Climb Bio held its Annual Meeting of stockholders on June 8, 2026, with voting results on multiple proposals: election of directors Alexander Cumbo and Douglas Williams, ratification of PricewaterhouseCoopers LLP as auditor, rejection of a director removal for cause amendment, and approval of the 2021 Equity Incentive Plan Amendment to include prefunded warrants in the automatic share pool increase mechanism.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from First Advantage's June 5, 2026 Annual Meeting of Stockholders. The filing reports final vote tallies for three proposals: election of Class II directors (James L. Clark, Bridgett R. Price, Mark Gillett), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, and the disclosure is material as it documents the outcome of the annual shareholder meeting and confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 disclosure reports the final results of Bumble Inc.'s 2026 Annual Meeting of Stockholders held on June 4, 2026, including voting outcomes on three proposals: election of three Class II directors (R. Lynn Atchison, Amy M. Griffin, and Sissie L. Hsiao), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides vote tallies certified by the independent inspector of election, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Savara held its annual meeting of stockholders on June 4, 2026, at which shareholders elected six board directors and approved four proposals including a certificate amendment, equity plan increase, auditor ratification, and an advisory vote on executive compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from Four Corners Property Trust's June 4, 2026 annual meeting of stockholders. The filing presents final voting tallies for three proposals: election of eight directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly reports the vote counts and outcomes for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Paymentus Holdings' 2026 Annual Meeting held on June 5, 2026. The filing reports voting outcomes on four matters: election of three Class II directors (Jody Davids, Adam Malinowski, and Gary Trainor), ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and advisory vote on say-on-pay frequency (one year). The detailed vote tallies and high participation rate (97% of voting power present) are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from Duluth Holdings' June 3, 2026 annual meeting, covering three proposals: election of eight directors, advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. The filing presents detailed vote tallies by share class for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
Item 5.07
Jaguar Health held its 2026 Annual Meeting of Stockholders on June 8, 2026, with shareholders voting on five proposals including election of a Class II director, ratification of auditors, and approval of dilutive issuances to C/M Capital Master Fund representing more than 19.99% of outstanding shares under two separate agreements (ELOC and Preferred Stock Purchase Agreement).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Palladyne AI Corp. held its Annual Meeting on or before June 8, 2026, with shareholders voting on four proposals: election of Class II director Dennis Weibling, ratification of KPMG LLP as independent auditor, approval of an amendment to the 2021 Equity Incentive Plan increasing available shares by 4,500,000, and approval of restricted stock unit awards totaling 5,360,659 shares to senior executives.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 filing discloses the final voting results from NeuroPace's June 5, 2026 Annual Meeting of Stockholders, including the election of Class II directors (Lisa Andrade and Scott Huennekens) and ratification of PricewaterhouseCoopers LLP as the independent auditor. The disclosure presents vote tallies (For, Against, Withhold, Abstain, Broker Non-Votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from ARKO Corp.'s 2026 Annual Meeting held on June 4, 2026. The filing presents final voting tallies for three proposals: election of six directors, advisory approval of named executive officer compensation, and ratification of Grant Thornton LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material disclosure of shareholder meeting outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Garmin held its annual general meeting on June 5, 2026, with shareholders voting on 14 proposals including approval of financial statements, director elections, executive compensation approvals, and auditor ratification. All matters were approved by shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from AN2 Therapeutics' June 3, 2026 annual meeting, reporting the certified voting outcomes for two proposals: (1) election of three Class I directors (Kabeer Aziz, Gilbert Lynn Marks, M.D., and Rob Readnour, Ph.D.) and (2) ratification of PricewaterhouseCoopers LLP as independent auditor. The filing directly matches Item 5.07 requirements and provides detailed vote tallies including votes for/against, withheld votes, and broker non-votes. Director elections are material governance events affecting board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from Ooma's June 4, 2026 annual meeting, covering three proposals: election of Class II directors (Butenhoff and Mann), ratification of KPMG LLP as independent auditor, and advisory vote on named executive officer compensation. The filing reports final voting tallies for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
DaVita disclosed the final certified results of its June 4, 2026 Annual Meeting of Stockholders, including voting outcomes on the election of nine directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
The filing discloses results of the Company's 2026 Annual Meeting of Shareholders held on June 5, 2026, with detailed voting tabulations for four proposals: election of five directors (Proposal 1), approval of bylaw amendment establishing a staggered board structure (Proposal 2), ratification of HTL International, LLC as independent auditor (Proposal 3), and adjournment authority (Proposal 4). Item 5.07 explicitly presents certified voting results from Broadridge Financial Solutions, Inc., the appointed Inspector of Elections, making this a classic shareholder_vote_results disclosure. The bylaw amendment establishing board classification is material to governance structure and investor assessment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from the June 5, 2026 Annual Meeting of Stockholders under Item 5.07. The filing presents final voting tallies for four proposals: election of nine directors (including one designated by Apax Investor), advisory approval of executive compensation, and ratification of KPMG LLP as independent auditor. These are routine but material governance matters that affect board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes on three proposals: election of seven directors, ratification of Wipfli LLP as independent auditor, and approval of a Stock Plan amendment to increase authorized shares by 200,000. All three proposals passed with clear majorities, and the disclosure includes detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, BROKER NON-VOTE) for each matter.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from Fuel Tech's Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes on three proposals: election of four directors (Vincent J. Arnone, Douglas G. Bailey, Sharon L. Jones, and Dennis L. Zeitler), ratification of RSM US LLP as independent auditor, and an advisory vote on executive compensation, with detailed vote tallies for each matter. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 discloses the complete results of Appian's June 3, 2026 annual stockholder meeting, including voting outcomes on five proposals: election of eight directors, ratification of BDO USA as independent auditor, advisory approval of named executive officer compensation, frequency of future advisory compensation votes, and approval of the amended 2017 Equity Incentive Plan. The detailed vote tallies for each proposal and director nominee are material to investors assessing corporate governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
SI-BONE held its Annual Meeting of Stockholders on June 8, 2026, with shareholders voting on three proposals: election of directors (Jeffrey W. Dunn and John G. Freund, M.D.), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of executive compensation. All three matters passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
Item 5.07 discloses the results of BTCS Inc.'s 2026 Annual Meeting of Shareholders held on June 8, 2026, including voting outcomes for director elections (Charles Allen, Charles Lee, Ashley DeSimone), auditor ratification (Forvis Mazars, LLP), and three equity plan amendments. All proposals passed, with director elections requiring plurality votes and other matters requiring majority approval. This is a material shareholder vote result disclosure as required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from MariMed Inc.'s June 4, 2026 Annual Meeting of Stockholders. The filing reports the specific vote tallies for two proposals: election of four directors (Jon R. Levine, Edward Gildea, David Allen, and Eva Selhub, M.D.) and advisory approval of M&K CPAs PLLC as independent auditors for fiscal 2026. The detailed vote counts (FOR, WITHHELD, BROKER NON-VOTE for directors; FOR, AGAINST, ABSTAIN for auditors) are the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Smart Sand held its Annual Meeting on June 2, 2026, with stockholders voting on five proposals: election of two Class I directors (Sharon Spurlin and Timothy J. Pawlenty), ratification of Grant Thornton LLP as auditor, advisory approval of named executive officer compensation, approval of the 2026 Equity Incentive Plan, and approval of the 2026 Employee Stock Purchase Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Avalo Therapeutics held its Annual Meeting of Stockholders on June 2, 2026, with voting results on three proposals: election of seven board directors, approval of the amended and restated 2016 ESPP, and ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from SAIC's Annual Meeting of Stockholders held on June 3, 2026, covering five distinct matters: election of ten directors, say-on-pay advisory vote, say-on-pay frequency vote, 2023 Equity Incentive Plan share authorization increase, and auditor ratification. The filing presents final vote tallies for each proposal, which is the core content required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 disclosure reports the final voting results from Intuitive Machines' Annual Meeting of Stockholders held on June 4, 2026. The filing presents tabulated results for two proposals: election of Class III directors (Dr. Kamal Ghaffarian and Stephen Altemus) and ratification of Grant Thornton LLP as independent auditor. Both proposals passed with substantial majorities, and the disclosure is material as it confirms the composition of the board and auditor for the fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from Prime Medicine's June 5, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: (i) election of Michael Kelly and David Schenkein, M.D. as Class I Directors, and (ii) ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstentions, Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 disclosures. Director elections and auditor ratification are material governance matters affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of FIGS' 2026 annual meeting of stockholders held on June 3, 2026. The filing presents voting results for three proposals: election of three Class II directors (Heather Hasson, Kenneth Lin, and Melanie Whelan), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed. This is a material disclosure as shareholder votes on director elections and auditor ratification directly affect corporate governance and investor confidence.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Ameresco held its 2026 Annual Meeting of Stockholders with four proposals voted on: election of two class I directors (Claire Hughes Johnson and Frank V. Wisneski), ratification of RSM US LLP as independent auditor, approval of a 3.2 million share increase to the 2020 Stock Incentive Plan, and an advisory vote on named executive officer compensation. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 filing discloses the final voting results from 10x Genomics' annual meeting of stockholders held on June 4, 2026, covering three proposals: election of three Class I directors (Serge Saxonov, Benjamin J. Hindson, and John R. Stuelpnagel), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
Item 5.07
This Item 5.07 filing discloses the final voting results from MarketWise's June 4, 2026 Annual Meeting of Stockholders on four proposals: election of directors (Matthew Turner), a say-on-pay advisory vote (which failed to pass), a say-on-frequency proposal (approved for one-year intervals), and ratification of Grant Thornton LLP as independent auditor. The failure of the say-on-pay proposal is material to investors as it signals stockholder dissatisfaction with executive compensation, warranting disclosure of the specific vote tallies.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
WillScot Holdings held its Annual Meeting of stockholders and voted on five proposals: election of nine directors, ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, and approval of the 2026 Incentive Award Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →